Show results for
Refine by
Disease Control Equipment Supplied In France
5 equipment items found
Manufactured by:TSI Incorporated based inShoreview, MINNESOTA (USA)
To limit the spread of disease through a facility, patients suspected of having diseases spread through the air must be placed in negative pressure rooms, airborne infection isolation rooms. Similarly, immune-compromised patients at risk of contracting diseases should stay in positive pressure, protective environment rooms. PRESSURA™ room ...
Manufactured by:TSI Incorporated based inShoreview, MINNESOTA (USA)
Since 1994, the US Center for Disease Control has required health-care facilities to house patients with infections potentially spread through the air in negative pressure rooms. Similarly, other organizations require positive pressure for surgical suites and areas with immune-compromised patients to limit the chances of infection spreading through the facility. ...
by:Valneva SE based inSaint-Herblain, FRANCE
IXIARO® is a vaccine indicated for the prevention of disease caused by JE virus, approved for use in individuals 2 months of age and older. Severe allergic reaction after a previous dose of IXIARO®, any other JEV vaccine, or any component of IXIARO®, including protamine sulfate - a compound known to cause hypersensitivity reactions in some individuals - is a contraindication to ...
Manufactured by:OSE Immunotherapeutics based inNantes, FRANCE
OSE-230 is an agonist antibody against ChemR23, also known as chemerin chemokine-like receptor 1 (CMKLR1), a G-protein coupled receptor (GPCR) expressed on myeloid immune cells known to modulate inflammation. Persistent inflammation is a characteristic feature of all chronic inflammatory or autoimmune diseases and if not controlled or resolved, it can lead to ...
Manufactured by:OSE Immunotherapeutics based inNantes, FRANCE
Tedopi®, OSE Immunotherapeutics’s most advanced product and therapeutic neo-epitope-based vaccine, is a proprietary combination of nine optimized neo-epitopes, selected and optimized from 5 tumoral antigens to activate specifically T cells, plus one epitope giving universal helper T cell response targeting T cell ...